Your browser doesn't support javascript.
loading
Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study.
Palaniyappan, Naaventhan; Peach, Emily; Pearce, Fiona; Dhaliwal, Amritpal; Campos-Varela, Isabel; Cant, Matthew R; Dopazo, Cristina; Trotter, James; Divani-Patel, Sapna; Hatta, Ayiesha A Z; Hopkins, Laurence; Testa, Giuliano; Bilbao, Angela; Kasmani, Zain; Faloon, Sarah; Mirza, Darius F; Klintmalm, Goran B; Bilbao, Itxarone; Asrani, Sumeet K; Rajoriya, Neil; Aravinthan, Aloysious D.
Afiliación
  • Palaniyappan N; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, UK.
  • Peach E; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, UK.
  • Pearce F; Lifespan and Population Health, School of Medicine, University of Nottingham, UK.
  • Dhaliwal A; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, UK.
  • Campos-Varela I; Lifespan and Population Health, School of Medicine, University of Nottingham, UK.
  • Cant MR; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Dopazo C; Liver Unit, Department of Medicine, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Trotter J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
  • Divani-Patel S; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Hatta AAZ; Department of Hepatobiliopancreatic Surgery and Transplants, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hopkins L; Baylor University Medical Center, Dallas, Texas, USA.
  • Testa G; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Bilbao A; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Kasmani Z; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Faloon S; Baylor University Medical Center, Dallas, Texas, USA.
  • Mirza DF; Department of Hepatobiliopancreatic Surgery and Transplants, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Klintmalm GB; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Bilbao I; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Asrani SK; The Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Rajoriya N; Centre for Liver and Gastrointestinal Research, NIHR Birmingham Biomedical Research, University of Birmingham, Birmingham, UK.
  • Aravinthan AD; Baylor University Medical Center, Dallas, Texas, USA.
Liver Transpl ; 30(2): 170-181, 2024 02 01.
Article en En | MEDLINE | ID: mdl-37589505
ABSTRACT
The long-term (>5 y) outcomes following liver transplantation (LT) have not been extensively reported. The aim was to evaluate outcomes of LT recipients who have survived the first 5 years. A multicenter retrospective analysis of prospectively collected data from 3 high volume LT centers (Dallas-USA, Birmingham-UK, and Barcelona-Spain) was undertaken. All adult patients, who underwent LT since the inception of the program to December 31, 2010, and survived at least 5 years since their LT were included. Patient survival was the primary outcome. A total of 3682 patients who survived at least 5 years following LT (long-term survivors) were included. Overall, median age at LT was 52 years (IQR 44-58); 53.1% were males; and 84.6% were Caucasians. A total of 49.4% (n=1820) died during a follow-up period of 36,828 person-years (mean follow-up 10 y). A total of 80.2% (n=1460) of all deaths were premature deaths. Age-standardized all-cause mortality as compared to general population was 3 times higher for males and 5 times higher for females. On adjusted analysis, besides older recipients and older donors, predictors of long-term mortality were malignancy, cardiovascular disease, and dialysis. Implementation of strategies such as noninvasive cancer screening, minimizing immunosuppression, and intensive primary/secondary cardiovascular prevention could further improve survival.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Trasplante de Hígado Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Trasplante de Hígado Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido